Management of Apixaban for Melanoma Excision

Perioperative Management of Apixaban

The American Society of Anesthesiologists recommends that apixaban be temporarily interrupted for 24 hours prior to the forearm melanoma excision procedure without reversal, as this represents a low bleeding risk procedure 1
Excision of melanoma on the forearm is considered a low bleeding risk procedure with minimal risk of uncontrollable or critical bleeding 1
Reversal agents are not indicated for routine perioperative management of apixaban in low bleeding risk procedures 1
For patients on apixaban for DVT treatment, the American College of Chest Physicians suggests that apixaban should be discontinued 24 hours before the forearm melanoma excision 1
No bridging therapy with heparin is required for this temporary interruption, as recommended by the American Society of Anesthesiologists 1

Patients with a history of DVT have an ongoing risk of recurrent thromboembolism, requiring prompt resumption of anticoagulation, according to the American Heart Association 2
Reversal agents should be reserved for life-threatening bleeding or emergency procedures with high bleeding risk, as stated by the American Society of Anesthesiologists 1

If the patient has impaired renal function, the interruption period may need to be extended, as apixaban has approximately 27% renal elimination, according to the National Comprehensive Cancer Network 3
For patients with severe renal impairment (CrCl <15 mL/min), apixaban should be avoided altogether, as recommended by the National Comprehensive Cancer Network 3
The American Thoracic Society notes that apixaban should be avoided in patients with severe renal impairment (CrCl <15 mL/min) 4

Monitor the surgical site for bleeding after resuming apixaban, as recommended by the American Society of Anesthesiologists 1
Failure to resume anticoagulation promptly after adequate hemostasis is achieved may increase thrombotic risk, according to the American Society of Anesthesiologists 1
Using bridging anticoagulation when not indicated may increase bleeding risk without benefit, as stated by the American Society of Anesthesiologists 1